Literature DB >> 33664966

Late effects of cancer treatment: consequences for long-term brain cancer survivors.

Montse Alemany1, Roser Velasco1, Marta Simó1, Jordi Bruna1.   

Abstract

Late adverse effects of cancer treatments represent a significant source of morbidity and also financial hardship among brain tumor patients. These effects can be produced by direct neurologic damage of the tumor and its removal, and/or by complementary treatments such as chemotherapy and radiotherapy, either alone or combined. Notably, young adults are the critical population that faces major consequences because the early onset of the disease may affect their development and socioeconomic status. The spectrum of these late adverse effects is large and involves multiple domains. In this review we classify the main long-term adverse effects into 4 sections: CNS complications, peripheral nervous system complications, secondary neoplasms, and Economic impact. In addition, CNS main complications are divided into nonfocal and focal symptoms. Owing to all the secondary effects mentioned, it is essential for physicians to have a high level of clinical suspicion to prevent and provide early intervention to minimize their impact.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  adverse events; brain tumors; glioma; long-term survivors; metastases

Year:  2020        PMID: 33664966      PMCID: PMC7906268          DOI: 10.1093/nop/npaa039

Source DB:  PubMed          Journal:  Neurooncol Pract        ISSN: 2054-2577


  97 in total

1.  Treatment burden and long-term health deficits of patients with low-grade gliomas or glioneuronal tumors diagnosed during the first year of life.

Authors:  Anthony P Y Liu; Camden Hastings; Shengjie Wu; Johnnie K Bass; Andrew M Heitzer; Jason Ashford; Robert Vestal; Mary E Hoehn; Yahya Ghazwani; Sahaja Acharya; Heather M Conklin; Frederick Boop; Thomas E Merchant; Amar Gajjar; Ibrahim Qaddoumi
Journal:  Cancer       Date:  2019-01-08       Impact factor: 6.860

2.  Reversible, strokelike migraine attacks in patients with previous radiation therapy.

Authors:  J D Bartleson; Karl N Krecke; Brian P O'Neill; Paul D Brown
Journal:  Neuro Oncol       Date:  2003-04       Impact factor: 12.300

3.  Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.

Authors:  Victor A Levin; Luc Bidaut; Ping Hou; Ashok J Kumar; Jeffrey S Wefel; B Nebiyou Bekele; Jai Grewal; Sujit Prabhu; Monica Loghin; Mark R Gilbert; Edward F Jackson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-01       Impact factor: 7.038

4.  Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up.

Authors:  Linda Douw; Martin Klein; Selene Saa Fagel; Josje van den Heuvel; Martin Jb Taphoorn; Neil K Aaronson; Tjeerd J Postma; W Peter Vandertop; Jacob J Mooij; Rudolf H Boerman; Guus N Beute; Jasper D Sluimer; Ben J Slotman; Jaap C Reijneveld; Jan J Heimans
Journal:  Lancet Neurol       Date:  2009-08-07       Impact factor: 44.182

5.  Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma.

Authors:  Bree R Eaton; Natia Esiashvili; Sungjin Kim; Briana Patterson; Elizabeth A Weyman; Lauren T Thornton; Claire Mazewski; Tobey J MacDonald; David Ebb; Shannon M MacDonald; Nancy J Tarbell; Torunn I Yock
Journal:  Neuro Oncol       Date:  2015-12-19       Impact factor: 12.300

6.  Cognitive and brain structural changes in long-term oligodendroglial tumor survivors.

Authors:  Nuria Cayuela; Esteban Jaramillo-Jiménez; Estela Càmara; Carles Majós; Noemi Vidal; Anna Lucas; Miguel Gil-Gil; Francesc Graus; Jordi Bruna; Marta Simó
Journal:  Neuro Oncol       Date:  2019-11-04       Impact factor: 12.300

Review 7.  Cerebral radiation necrosis.

Authors:  Pierre Giglio; Mark R Gilbert
Journal:  Neurologist       Date:  2003-07       Impact factor: 1.398

Review 8.  Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy.

Authors:  Jörg Dietrich; Michelle Monje; Jeffrey Wefel; Christina Meyers
Journal:  Oncologist       Date:  2008-11-19

9.  (18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment.

Authors:  Karlo J Lizarraga; Martin Allen-Auerbach; Johannes Czernin; Antonio A F DeSalles; William H Yong; Michael E Phelps; Wei Chen
Journal:  J Nucl Med       Date:  2013-10-28       Impact factor: 10.057

10.  Evaluation of carotid angioplasty and stenting for radiation-induced carotid stenosis.

Authors:  Simon C H Yu; Winnie X Y Zou; Yannie O Y Soo; Lily Wang; Joyce Wai Yi Hui; Anne Y Y Chan; Kwok Tung Lee; Vincent H L Ip; Florence S Y Fan; Annie L C Chan; Lawrence K S Wong; Thomas W Leung
Journal:  Stroke       Date:  2014-04-03       Impact factor: 7.914

View more
  5 in total

Review 1.  Neurological side effects of radiation therapy.

Authors:  J Jacob; L Feuvret; J-M Simon; M Ribeiro; L Nichelli; C Jenny; D Ricard; D Psimaras; K Hoang-Xuan; P Maingon
Journal:  Neurol Sci       Date:  2022-02-11       Impact factor: 3.307

Review 2.  [Physical long-term consequences of cancer].

Authors:  Lisa Ernst; Georgia Schilling
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2022-03-21       Impact factor: 1.513

Review 3.  Combinatorial therapeutic strategies for enhanced delivery of therapeutics to brain cancer cells through nanocarriers: current trends and future perspectives.

Authors:  Xiande Wang; Cheng Wu; Shiming Liu; Deqing Peng
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 4.  Diagnosis and Treatment of Pineal Region Tumors in Adults: A EURACAN Overview.

Authors:  Giuseppe Lombardi; Pietro Luigi Poliani; Renzo Manara; Moncef Berhouma; Giuseppe Minniti; Emeline Tabouret; Evangelia Razis; Giulia Cerretti; Vittorina Zagonel; Michael Weller; Ahmed Idbaih
Journal:  Cancers (Basel)       Date:  2022-07-27       Impact factor: 6.575

Review 5.  Challenging Hurdles of Current Targeting in Glioblastoma: A Focus on Immunotherapeutic Strategies.

Authors:  Vassilis Genoud; Denis Migliorini
Journal:  Int J Mol Sci       Date:  2021-03-28       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.